Reunion Neuroscience Inc Stock, NASDAQ:REUN
30 Duncan Street, Lower North Suite, Toronto, Ontario M5V 2C3
Number of Employees: 194
Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.